Cardiogenic shock is a life-threatening condition with a very poor prognosis. Many disorders may contribute to the development of shock. Of them, acute myocardial infarction is the main culprit. Despite tremendous progress in the field of interventional cardiology, in-hospital and long-term mortality still exceeds 50%. Data from large controlled trials on cardiogenic shock are scarce due to ethical reasons. Nevertheless, there is a chance for acceptable long-term survival in patients treated aggressively. The aim of this review is to summarise the key points of differential diagnosis and to emphasise that in most cases of shock due to acute myocardial infarction primary coronary intervention is the treatment of choice
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Background: Mortality in acute myocardial infarction (MI) complicated by cardiogenic shock approache...
The current review aimed to highlight the update management in patients with ischemic Cardiogenic sh...
International audienceUp to 10% of acute coronary syndromes are complicated by cardiogenic shock (CS...
Cardiogenic shock continues to be the most common cause of death in Patients hospitalized with acute...
Cardiogenic shock (CS) is a critical condition which often complicates the evolution of an acute myo...
Cardiogenic shock (CS) is a critical condition which often complicates the evolution of an acute myo...
Cardiogenic shock complicating acute myocardial infarction (MI) carries a high mortality which in so...
AbstractOBJECTIVESThis SHOCK Study report seeks to provide an overview of patients with cardiogenic ...
Hospital survival of patients with acute myocardial infarction complicated by cardiogenic shock has ...
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Background: Mortality in acute myocardial infarction (MI) complicated by cardiogenic shock approache...
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Background: Mortality in acute myocardial infarction (MI) complicated by cardiogenic shock approache...
The current review aimed to highlight the update management in patients with ischemic Cardiogenic sh...
International audienceUp to 10% of acute coronary syndromes are complicated by cardiogenic shock (CS...
Cardiogenic shock continues to be the most common cause of death in Patients hospitalized with acute...
Cardiogenic shock (CS) is a critical condition which often complicates the evolution of an acute myo...
Cardiogenic shock (CS) is a critical condition which often complicates the evolution of an acute myo...
Cardiogenic shock complicating acute myocardial infarction (MI) carries a high mortality which in so...
AbstractOBJECTIVESThis SHOCK Study report seeks to provide an overview of patients with cardiogenic ...
Hospital survival of patients with acute myocardial infarction complicated by cardiogenic shock has ...
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Background: Mortality in acute myocardial infarction (MI) complicated by cardiogenic shock approache...
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfu...
Background: Mortality in acute myocardial infarction (MI) complicated by cardiogenic shock approache...
The current review aimed to highlight the update management in patients with ischemic Cardiogenic sh...